Clinical and Epidemiological Features of Death with COVID-19 in Karnali Province of Nepal
Abstract
Background: Coronavirus disease (COVID-19) has rapidly spread to many countries and increased mortality worldwide. Most deaths were either elderly or have underlying medical problems and even young individuals have died from COVID-19.We sought to analyze the epidemiological and clinical profiles of COVID-19 related deaths in Karnali Province, Nepal.
Methods: We studied COVID-19 deaths from 19 May 2020 to 25 December 2020. Information from all districts of Karnali Province were included in this study. Demographic characteristics and geographic distribution map of the death toll in each district over time was analyzed. Quantum GIS(QGIS) 3.16.2 version was used to plot the deaths on maps and IBM SPSS Statistics 25 to perform statistical analysis
Results: As of December 25, 2020, a total of 25 deaths were reported. Mean age of death was 52 (SD 20.99) years. Most of the deaths were distributed in age group of 50 years and above. Additionally, the male to female ratio was 5:2. A total of 56% of the deaths in Karnali were with underlying diseases and was more prominent among males. Most of the cases were centralized in Surkhet district with highest death rate in Birendranagar municipality.
Conclusion: COVID-19 poses a substantial threat to the old age population with co-morbid health condition. The geographical distributions showed that the epidemic in the Surkhet district is more serious than that in the surrounding districts. Case investigation, Contract tracing and dedicated ICU ventilator service for critical cases are essential for response of Pandemic.
References
World Health Organization,Regional Office for Eastern Mediterranean. Health Topics. [online] Available at: <http://www.emro.who.int/health-topics/corona-virus/questions-and-answers.html> [Accessed 25 December 2020]. [Full text]
Coronavirus [Internet]. Who.int. 2020 [cited 25 December 2020]. Available from: https://www.who.int/health-topics/coronavirus. [Full text]
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KS, Lau EH, Wong JY, Xing X. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020;382:1199-207 10.1056/NEJMoa2001316. [Full text] [PubMed] [PMID]
World Health Organization. (2020) Novel Coronavirus (2019-nCoV): situation report, 22. World Health Organization. https://apps.who.int/iris/handle/10665/330991. [Full text]
Joshi J, Mishra P, Kamar SB, Sharma ND, Parajuli J, Sharma S, Pandey HR. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal. Age. 2020 Apr 20;34(20):40. https://doi.org/10.33314/jnhrc.v18i1.2602. [Full text] [PubMed] [PMID]
Ministry of Social Development,Health Service Diretorate,Surkhet.Health sector response to COVID-19. SitRep-(1-3). Accessed 24 December 2020. [Main Site]
MoHP. COVID-19 Situtation Reports of Ministry of Health and Population,Government of Nepal:situation report,320.Available online at: https://covid19.mohp.gov.np (accessed December 25, 2020). [Full text]
WHO. COVID-19 Weekly Epidemiological Update. 2020;(December-20).Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.Accessed 26 December 2020. [Full text]
Panthee B, Dhungana S, Panthee N, Gyawali S, Paudel A, Panthee S. Clinical and epidemiological features of COVID-19 deaths in Nepal. New Microbes and New Infections. 2020;38:100797. https://doi.org/10.1016/j.nmni.2020.100797. [Full text] [PubMed] [PMID]
Ministry of Social Development,Health Service Diretorate,Surkhet.Health sector response to COVID-19. SitRep-276. Accessed 26 December 2020. [Main Site]
DOHS. Health Management Information System,HMIS indicator 2070.Available online at: https://dohs.gov.np/publications/.Accessed 20 December 2020. [Full text]
Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, Felix SE, Tie Y, Fullerton KE. Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020. Morbidity and Mortality Weekly Report. 2020; 69(24):759. http://dx.doi.org/10.15585/mmwr.mm6924e2. [Full text] [PubMed] [PMID]
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020 ;323(18):1775-6. https://doi.org/10.1001/jama.2020.4683. [Full text] [PubMed] [PMID]
Laxminarayan R, Wahl B, Dudala SR, Gopal K, Neelima S, Reddy KJ, Radhakrishnan J, Lewnard JA. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 2020; 370(6517):691-7. https://doi.org/10.1126/science.abd7672. [Full text] [PubMed] [PMID]
Dey SK, Rahman MM, Siddiqi UR, Howlader A. Exploring epidemiological behavior of novel coronavirus (COVID-19) outbreak in Bangladesh. SN comprehensive clinical medicine. 2020; 2(10):1724-32. https://doi.org/10.1007/s42399-020-00477-9. [Full text] [PubMed]
de Souza WM, Buss LF, da Silva Candido D, Carrera JP, Li S, Zarebski A, Vincenti-Gonzalez M, Messina J, da Silva Sales FC, dos Santos Andrade P, Prete CA. Epidemiological and clinical characteristics of the early phase of the COVID-19 epidemic in Brazil. medRxiv. 2020 2020;4(8):856-65. [Full text]
Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari NJ, Izadi M, Qazvini A, Dorostkar R. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study. Journal of Clinical Virology. 2020;127:104378: https://doi.org/10.1016/j.jcv.2020.104378. [Full text] [PubMed] [PMID]
World Health Organization,Regional Office for Sout East Asia. 2018 Health SDG Profile: Nepal.Available online at: https://apps.who.int/iris/handle. [Full text]
Chen L, Yu J, He W, Chen L, Yuan G, Dong F, Chen W, Cao Y, Yang J, Cai L, Wu D. Risk factors for death in 1859 subjects with COVID-19. Leukemia. 2020; 34(8):2173-83. https://doi.org/10.1038/s41375-020-0911-0. [Full text] [PubMed] [PMID]
Copyright (c) 2021 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.
On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/
